China’s biggest pharma firm invites PH to join COVID-19 vaccine trial
MANILA, Philippines — China’s biggest pharmaceutical company, the state-owned Sinopharm, has invited the Philippines to join its trial of a vaccine for the coronavirus disease (COVID-19), Health Secretary Francisco Duque III bared Wednesday at the Senate Committee of the Whole hearing.
“We have a letter from China, from Sinopharm, China’s biggest pharmaceutical company, which offered to include us in its global clinical trial for their newly-developed vaccine,” Duque said.
Previously, Sinopharm also extended a similar invitation to Pakistan.
In the Senate hearing, Duque also revealed that 148 patients had agreed to be part of the World Health Organization’s (WHO) Solidarity Trial for COVID-19 treatment.
As of Wednesday, the Philippines has 13,221 COVID-19 cases, of whom 842 have died while 2,932 have recovered.
Subscribe to our daily newsletter
The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.
Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.